During the last session, Transmedics Group Inc (NASDAQ:TMDX)’s traded shares were 0.78 million, with the beta value of the company hitting 2.09. At the end of the trading day, the stock’s price was $127.12, reflecting an intraday loss of -0.45% or -$0.57. The 52-week high for the TMDX share is $177.37, that puts it down -39.53 from that peak though still a striking 56.73% gain since the share price plummeted to a 52-week low of $55.00. The company’s market capitalization is $4.30B, and the average trade volume was 1.09 million shares over the past three months.
Transmedics Group Inc (TMDX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.70. TMDX has a Sell rating from 0 analyst(s) out of 7 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it.
Transmedics Group Inc (NASDAQ:TMDX) trade information
Transmedics Group Inc (TMDX) registered a -0.45% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.45% in intraday trading to $127.12, hitting a weekly high. The stock’s 5-day price performance is 3.06%, and it has moved by 38.16% in 30 days. Based on these gigs, the overall price performance for the year is -11.02%.
The consensus price target of analysts on Wall Street is $105, which implies a decrease of -21.07% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $90 and $120 respectively. As a result, TMDX is trading at a premium of 5.6% off the target high and 29.2% off the low.
While earnings are projected to return 81.95% in 2025, the next five years will return 45.39% per annum.
TMDX Dividends
Transmedics Group Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 2.65 million shares, is of BLACKROCK INC.’s that is approximately 7.9879% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $398.47 million.
Also, the Mutual Funds coming in first place with the largest holdings of Transmedics Group Inc (TMDX) shares are iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . Data provided on Apr 30, 2025 indicates that iShares Trust-iShares Core S&P Small-Cap ETF owns about 2.04 shares. This amounts to just over 6.02 percent of the company’s overall shares, with a $258.78 million market value. The same data shows that the other fund manager holds slightly less at 1.0, or about 2.97% of the stock, which is worth about $127.7 million.
